8-KOther EventsExhibits & Filings

CME GROUP INC. 8-K Report, Corporate Update (Jun 23, 2008)

Filed June 23, 2008For Securities:CME

Summary

CME Group Inc. (CME) announced on June 23, 2008, significant initiatives to return capital to its shareholders. The board of directors has authorized a substantial share buyback program of up to $1.1 billion of Class A common stock, which is expected to be executed over an 18-month period through various methods including open market purchases, accelerated programs, tender offers, or private negotiations. Furthermore, CME Group plans to declare a special dividend of $5.00 per common share. This dividend payment is contingent upon the successful completion of the company's pending acquisition of NYMEX Holdings, Inc. These actions signal a strong commitment by CME Group's management to enhance shareholder value and return profits generated by the company's operations.

Key Highlights

  • 1CME Group's board authorized a share buyback program of up to $1.1 billion.
  • 2The share repurchase program will be executed over a period of up to 18 months.
  • 3Repurchases can occur through open market transactions, accelerated programs, tender offers, or private negotiations.
  • 4CME Group intends to declare a special dividend of $5.00 per common share.
  • 5The special dividend is conditional on the closing of the pending transaction with NYMEX Holdings, Inc.
  • 6These initiatives are designed to return capital to shareholders.

Frequently Asked Questions

CME Group's board of directors has authorized a share buyback program with a total value of up to $1.1 billion of its Class A common stock.

The share buyback program is authorized to take place over a period of up to 18 months from the announcement date.

The special dividend of $5.00 per common share is planned, but it is contingent upon the resolution and completion of CME Group's pending transaction with NYMEX Holdings, Inc.

CME Group intends to conduct repurchases through various methods, including open market purchases, an accelerated program, a tender offer, or privately negotiated transactions, in compliance with relevant SEC rules and regulations.